Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Prostatic Neoplasms 26Prostatic Neoplasms, Castration-Resistant 4Prostatic Diseases 3Neoplasm Metastasis 3Metastatic Castration-resistant Prostate Cancer 3Adenocarcinoma 3Urogenital Neoplasms 2Triple Negative Breast Neoplasms 2Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 2Male Urogenital Diseases 2Genital Diseases, Male 2Urogenital Diseases 1Sleep Initiation and Maintenance Disorders 1Prostate Cancer Metastatic 1Non-metastatic Castration-resistant Prostate Cancer 1Neoplasms by Site 1Neoplasms 1Metastatic Castration-resistant Prostate Neoplasms 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1High-Risk Localized Prostate Cancer 1Fatigue 1Depression 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Bulbo-Spinal Atrophy, X-Linked 1Advanced Solid Tumor 1

Interventions

Injections 12pembrolizumab 7toripalimab 5tislelizumab 5Oxaliplatin 3Gemcitabine 3Cisplatin 3Carboplatin 3trastuzumab deruxtecan 2spartalizumab 2lenvatinib 2atezolizumab 2Paclitaxel 2Nivolumab 2Immune Checkpoint Inhibitors 2Fulvestrant 2Fluorouracil 2Docetaxel 2Cyclophosphamide 2Cetuximab 2Bevacizumab 2Albumin-Bound Paclitaxel 2zimberelimab 1penpulimab 1olaparib 1niraparib 1nedaplatin 1fludarabine phosphate 1fludarabine 1enzalutamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Advanced Solid Tumor × darolutamide × Clear all
NCT06220864 2026-04-14

SNV1521 in Participants With Advanced Solid Tumors

Synnovation Therapeutics, Inc.

Phase 1 Recruiting
400 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡